Hovione is an international company with over 50 years’ experience in API development and compliant manufacture. With FDA inspected sites in the US, China, Ireland, and Portugal the company focuses on the most demanding customers, in the most regulated markets.
The company offers integrated API, particle design and formulation development and manufacturing. In the inhalation area, Hovione is the only independent company offering such a broad range of services.
Hovione’s specialist capabilities in pharmaceutical fine chemicals have been enhanced through an extensive range of advanced and proven enabling technology platforms to address specific formulation and bioavailability issues. These particle design technologies include spray drying, spray congealing, hot melt extrusion, wet milling, fluidized spray drying and freeze drying and are further complemented by our ability to manufacture your API (including potent APIs) or to perform formulation studies for inhalation development using Hovione’s dry powder inhalers or other inhalers.
Our cGMP spray drying facilities give our customers the ability to not only control particle size, but also the morphology of the product, which allows for the optimization of the particle and delivery characteristics of preformulated APIs. Hovione can perform a wide range of feasibility studies, from just a few grams to full scale commercial production, to meet your specific product requirements.
Our aim is to provide our customers with solutions for their complex drug delivery concerns.